Home/Filings/4/A/0001193805-25-000923
4/A//SEC Filing

Vitt Daniel 4/A

Accession 0001193805-25-000923

CIK 0001280776other

Filed

Jun 19, 8:00 PM ET

Accepted

Jun 20, 5:15 PM ET

Size

8.6 KB

Accession

0001193805-25-000923

Insider Transaction Report

Form 4/AAmended
Period: 2025-06-04
Vitt Daniel
DirectorCEO and Director
Transactions
  • Award

    Stock Option

    2025-06-05+1,558,0001,558,000 total
    Exercise: $0.77Exp: 2035-06-05Common Stock (1,558,000 underlying)
  • Purchase

    Common Stock

    2025-06-04$0.77/sh+15,000$11,55029,000 total
Holdings
  • Common Stock

    (indirect: See footnote)
    362,877
Footnotes (3)
  • [F1]The purchase was made in Euros and the price was converted into U.S. dollars based on the foreign currency exchange rate as of June 4, 2025 (at Euro 1.00 = U.S. dollar 1.1384).
  • [F2]362,877 shares of the Issuer's common stock are owned by Listrax UG (haftungsbeschrankt). The RP is Managing Director of Listrax UG and exercises voting and dispositive power over such shares.
  • [F3]25% of the shares underlying the option vest on the first anniversary of the grant date, with the remainder vesting in equal increments on each successive one-month anniversary thereafter for the next 36 months.

Documents

1 file

Issuer

IMMUNIC, INC.

CIK 0001280776

Entity typeother

Related Parties

1
  • filerCIK 0001773673

Filing Metadata

Form type
4/A
Filed
Jun 19, 8:00 PM ET
Accepted
Jun 20, 5:15 PM ET
Size
8.6 KB